- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 2b/3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)
This study, called ORION, is testing a new drug called AMX0035 for Progressive Supranuclear Palsy (PSP). Researchers want to see if the drug is safe and helps slow down the disease's progression. It's a late-stage trial, hoping to show clear benefits.
For: Progressive Supranuclear PalsyBulgaria · Austria · Netherlands - Active not recruitingPHASE3
Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment
This study is testing a new medicine called AMX0035 for people with Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neurone Disease. We want to see if it's safe and can help slow down the disease over 48 weeks compared to a dummy medicine.
For: Amyotrophic Lateral SclerosisUnited States · Belgium · France - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS)
This study is testing a new medicine, AMX0035, for people with Motor Neurone Disease (ALS). It aims to see if the medicine can slow down the disease's progression over 48 weeks, compared to a dummy medicine.
For: Amyotrophic Lateral Sclerosis (ALS)Netherlands · Poland · Germany